Turning air into water could become a solution for water-hungry Texas cities

Midland company called Tsunami Products could bring relief to drought-stricken Mathis in the form of a test pilot program ...
The Manila Times

Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

Approval for children aged 2 to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical trial program ...

Sanofi: Sanofi and Regeneron's Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria

Sanofi and Regeneron's Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria Approval for children aged two to 11 years with ...
Rutland Herald

Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day

Definium Therapeutics, Inc. (Nasdaq: DFTX) (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address the underlying ...
Seven Days

After a Rural Revolt, Dems Favor Rolling Back Act 250 Reforms

Just two years ago, lawmakers approved tougher development rules for rural areas. Facing harsh backlash and potential ...

St. Joe (JOE) Q2 2025 Earnings Call Transcript

I am Jorge Gonzalez, President, CEO and Chairman of The St. Joe Company. It is my pleasure to welcome you to the quarterly ...